ArticleOman medical journal2025
Antibiotic Use Among Hospitalized Patients with COVID-19 Infection (SARS-CoV-2 Omicron Variant) in Oman: A Single-center Retrospective Study.
Article in Oman medical journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Antibiotic Use, Bacterial Co-Infection, and Antimicrobial Resistance in Adults Hospitalized with COVID-19, Influenza, or RSV: A Systematic Review and Meta-Analysis.Antibiotics (Basel, Switzerland) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: To identify and evaluate the prescribing pattern of antibiotics among hospitalized patients with SARS-CoV-2, Omicron variant in Oman, focusing on the prevalence of antibiotic use, rates of simultaneous infection, and potential overuse. Methods: This retrospective study analyzed data from the electronic medical records of patients with COVID-19 caused by SARS-CoV-2 Omicron variant who were hospitalized at the Royal Hospital, Muscat, during December 2021-February 2022. Information on demographic and clinical details (including existing infections and comorbidities), hospital stays, and outcomes were collected. The prevalence and pattern of antibiotic use were examined, an association with their disease characteristics and simultaneous infection status were assessed. Statistical analysis was performed using R software. Associations between categorical variables were evaluated using chi-square test. Results: The participants were 176 hospitalized COVID-19 patients (mean age 59.3 ± 18.6 years), of whom 69.9% had mild disease and 22.7% had severe disease. Simultaneous infection (coinfection or superinfection) was present in 11 (6.3%) patients, including 7 (4.0%) bacterial infections as revealed by culture tests. Despite the low rate of simultaneous infections, 104 (59.1%) patients received antibiotics, as follows: ceftriaxone (45.2%), piperacillin and tazobactam (45.2%), and vancomycin (21.2%). Half of the patients who received antibiotics used them for only one to three days with a median duration of four days (range = 1-16). Antibiotic use was significantly associated with patient sex ( Conclusions: Despite low rates of confirmed bacterial infections, antibiotics were administered to majority of hospitalized patients with COVID-19 (Omicron variant). This finding emphasizes the need for strengthening antimicrobial stewardship to curb unnecessary antibiotic use and reduce the risk of antibiotic resistance during pandemics in Oman.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.